Mason Carrico

Stock Analyst at Stephens & Co.

(0)
# 4425
Out of 5,298 analysts
78
Total ratings
20.00%
Success rate
-13.73%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
VCYT Veracyte
Reiterates: Overweight
45 45
28.44 58.23% 6 Mar 26, 2025
OCX OncoCyte
Reiterates: Equal-Weight
4 4
2.92 36.99% 5 Mar 26, 2025
GH Guardant Health
Reiterates: Overweight
55 55
41.92 31.2% 5 Mar 26, 2025
AKYA Akoya Biosciences
Downgrades: Equal-Weight
4 2
1.26 42.86% 6 Mar 25, 2025
CTKB Cytek Biosciences
Reiterates: Overweight
6 6
3.75 60% 2 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
17 17
16.82 1.07% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
156 156
76.92 102.81% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
52 52
35 48.57% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
40 40
17.3 131.21% 9 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
1.19 110.08% 4 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
84 84
61.07 37.55% 3 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 13
13.07 -0.54% 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
20 20
8.3 140.96% 4 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
44.22 46.99% 1 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
41 41
19.08 114.88% 7 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
30 30
8 275% 5 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
125 125
139.57 -10.44% 4 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
19 19
8.8 115.91% 1 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
2 2
n/a n/a 4 Apr 19, 2024